Recent filings by Bristol-Myers Squibb Company

Published Title Summary
2026-08-07 08:50:22 SCHEDULE 13G - BRISTOL MYERS SQUIBB CO (0000014272) (Subject) Passive 5% Ownership Report SEC-SCHEDULE 13G filed by Bristol-Myers Squibb...
Passive 5% Ownership Report SEC-SCHEDULE 13G filed by Bristol-Myers Squibb Company on 2026-08-07 08:50:22-04:00
2026-07-30 11:10:38 10-Q - BRISTOL MYERS SQUIBB CO (0000014272) (Filer) Quarterly Report SEC-10-Q filed by Bristol-Myers Squibb Company on 2026-07-30...
Quarterly Report SEC-10-Q filed by Bristol-Myers Squibb Company on 2026-07-30 11:10:38-04:00
2026-07-30 07:05:39 8-K - BRISTOL MYERS SQUIBB CO (0000014272) (Filer)
Item 2.02: Results of Operations and Financial Condition
Item 7.01:...

Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits
2026-05-08 16:10:44 8-K - BRISTOL MYERS SQUIBB CO (0000014272) (Filer)
Item 5.07: Submission of Matters to a Vote of Security...

Item 5.07: Submission of Matters to a Vote of Security Holders
2026-04-30 11:44:13 10-Q - BRISTOL MYERS SQUIBB CO (0000014272) (Filer) Quarterly Report SEC-10-Q filed by Bristol-Myers Squibb Company on 2026-04-30...
Quarterly Report SEC-10-Q filed by Bristol-Myers Squibb Company on 2026-04-30 11:44:13-04:00
2026-04-30 07:01:58 8-K - BRISTOL MYERS SQUIBB CO (0000014272) (Filer)
Item 2.02: Results of Operations and Financial Condition
Item 7.01:...

Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits
2026-03-03 16:16:42 4 - Statement of changes in beneficial ownership of securities Statement of changes in beneficial ownership of securities by insiders...
Statement of changes in beneficial ownership of securities by insiders SEC-4 filed by Bristol-Myers Squibb Company on 2026-03-03 16:16:42-05:00
2026-02-11 11:35:11 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] Annual Report SEC-10-K filed by Bristol-Myers Squibb Company on 2026-02-11...
Annual Report SEC-10-K filed by Bristol-Myers Squibb Company on 2026-02-11 11:35:11-05:00
2026-02-05 07:07:45 8-K - Current report Filed: 2026-02-05 AccNo: 0000014272-26-000002 Size: 3 MB
Item 2.02: Results of...
Filed: 2026-02-05 AccNo: 0000014272-26-000002 Size: 3 MB
Item 2.02: Results of Operations and Financial Condition
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits
2026-02-03 16:40:10 4 - Statement of changes in beneficial ownership of securities Statement of changes in beneficial ownership of securities by insiders...
Statement of changes in beneficial ownership of securities by insiders SEC-4 filed by Bristol-Myers Squibb Company on 2026-02-03 16:40:10-05:00
2026-02-03 16:39:19 4 - Statement of changes in beneficial ownership of securities Statement of changes in beneficial ownership of securities by insiders...
Statement of changes in beneficial ownership of securities by insiders SEC-4 filed by Bristol-Myers Squibb Company on 2026-02-03 16:39:19-05:00
2026-02-03 16:36:45 4 - Statement of changes in beneficial ownership of securities Statement of changes in beneficial ownership of securities by insiders...
Statement of changes in beneficial ownership of securities by insiders SEC-4 filed by Bristol-Myers Squibb Company on 2026-02-03 16:36:45-05:00
2026-02-03 16:35:30 4 - Statement of changes in beneficial ownership of securities Statement of changes in beneficial ownership of securities by insiders...
Statement of changes in beneficial ownership of securities by insiders SEC-4 filed by Bristol-Myers Squibb Company on 2026-02-03 16:35:30-05:00
2026-02-03 16:34:04 4 - Statement of changes in beneficial ownership of securities Statement of changes in beneficial ownership of securities by insiders...
Statement of changes in beneficial ownership of securities by insiders SEC-4 filed by Bristol-Myers Squibb Company on 2026-02-03 16:34:04-05:00
2026-02-03 16:30:49 4 - Statement of changes in beneficial ownership of securities Statement of changes in beneficial ownership of securities by insiders...
Statement of changes in beneficial ownership of securities by insiders SEC-4 filed by Bristol-Myers Squibb Company on 2026-02-03 16:30:49-05:00
2026-02-03 16:29:24 4 - Statement of changes in beneficial ownership of securities Statement of changes in beneficial ownership of securities by insiders...
Statement of changes in beneficial ownership of securities by insiders SEC-4 filed by Bristol-Myers Squibb Company on 2026-02-03 16:29:24-05:00
2026-02-03 16:27:12 4 - Statement of changes in beneficial ownership of securities Statement of changes in beneficial ownership of securities by insiders...
Statement of changes in beneficial ownership of securities by insiders SEC-4 filed by Bristol-Myers Squibb Company on 2026-02-03 16:27:12-05:00
2026-02-03 16:25:34 4 - Statement of changes in beneficial ownership of securities Statement of changes in beneficial ownership of securities by insiders...
Statement of changes in beneficial ownership of securities by insiders SEC-4 filed by Bristol-Myers Squibb Company on 2026-02-03 16:25:34-05:00
2026-02-03 16:22:32 4 - Statement of changes in beneficial ownership of securities Statement of changes in beneficial ownership of securities by insiders...
Statement of changes in beneficial ownership of securities by insiders SEC-4 filed by Bristol-Myers Squibb Company on 2026-02-03 16:22:32-05:00
2026-02-03 16:20:34 4 - Statement of changes in beneficial ownership of securities Statement of changes in beneficial ownership of securities by insiders...
Statement of changes in beneficial ownership of securities by insiders SEC-4 filed by Bristol-Myers Squibb Company on 2026-02-03 16:20:34-05:00
2026-02-03 16:18:59 4 - Statement of changes in beneficial ownership of securities Statement of changes in beneficial ownership of securities by insiders...
Statement of changes in beneficial ownership of securities by insiders SEC-4 filed by Bristol-Myers Squibb Company on 2026-02-03 16:18:59-05:00
2026-01-12 10:20:51 8-K - Current report Filed: 2026-01-12 AccNo: 0001140361-26-000929 Size: 3 MB
Item 7.01: Regulation FD...
Filed: 2026-01-12 AccNo: 0001140361-26-000929 Size: 3 MB
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits
2026-01-05 16:16:11 4 - Statement of changes in beneficial ownership of securities Statement of changes in beneficial ownership of securities by insiders...
Statement of changes in beneficial ownership of securities by insiders SEC-4 filed by Bristol-Myers Squibb Company on 2026-01-05 16:16:11-05:00
2026-01-05 16:15:22 4 - Statement of changes in beneficial ownership of securities Statement of changes in beneficial ownership of securities by insiders...
Statement of changes in beneficial ownership of securities by insiders SEC-4 filed by Bristol-Myers Squibb Company on 2026-01-05 16:15:22-05:00
2026-01-05 16:14:20 4 - Statement of changes in beneficial ownership of securities Statement of changes in beneficial ownership of securities by insiders...
Statement of changes in beneficial ownership of securities by insiders SEC-4 filed by Bristol-Myers Squibb Company on 2026-01-05 16:14:20-05:00
2026-01-05 16:12:54 4 - Statement of changes in beneficial ownership of securities Statement of changes in beneficial ownership of securities by insiders...
Statement of changes in beneficial ownership of securities by insiders SEC-4 filed by Bristol-Myers Squibb Company on 2026-01-05 16:12:54-05:00
2026-01-05 16:11:03 4 - Statement of changes in beneficial ownership of securities Statement of changes in beneficial ownership of securities by insiders...
Statement of changes in beneficial ownership of securities by insiders SEC-4 filed by Bristol-Myers Squibb Company on 2026-01-05 16:11:03-05:00
2025-11-18 16:41:56 8-K - Current report Filed: 2025-11-18 AccNo: 0001140361-25-042607 Size: 937 KB
Item 8.01: Other Events
Item...
Filed: 2025-11-18 AccNo: 0001140361-25-042607 Size: 937 KB
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits
2025-11-10 16:06:36 8-K - Current report Filed: 2025-11-10 AccNo: 0001140361-25-041380 Size: 2 MB
Item 8.01: Other Events
Item...
Filed: 2025-11-10 AccNo: 0001140361-25-041380 Size: 2 MB
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits
2025-11-04 17:19:52 4 - Statement of changes in beneficial ownership of securities Statement of changes in beneficial ownership of securities by insiders...
Statement of changes in beneficial ownership of securities by insiders SEC-4 filed by Bristol-Myers Squibb Company on 2025-11-04 17:19:52-05:00